ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,595Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 278

$827K Total Retail Price of All Prescriptions

Rank: 45 out of 278

628 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 628 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 628 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 11,851 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 558 391 S3 1 1
OMEPRAZOLE 470 398 2 3
SIMVASTATIN 310 285 3 4
AMLODIPINE BESYLATE 298 286 4 7
LEVOTHYROXINE SODIUM 292 261 5 2
METOPROLOL SUCCINATE 290 283 6 10
GABAPENTIN 290 225 6 12
METFORMIN HCL 253 217 8 8
LOSARTAN POTASSIUM 245 212 9 24
FUROSEMIDE 245 207 9 6
TRAZODONE HCL 207 169 11 47
METOPROLOL TARTRATE 202 178 12 9
LISINOPRIL 196 160 13 5
BENAZEPRIL HCL 189 176 14 108
CLOPIDOGREL 184 175 15 20
PRAVASTATIN SODIUM 184 157 15 16
ZOLPIDEM TARTRATE 182 154 17 26
POTASSIUM CHLORIDE 168 142 18 17
AMLODIPINE BESYLATE-BENAZEPRIL 148 143 19 77
NEXIUM 146 75 20 14
MELOXICAM 145 125 21 37
SERTRALINE HCL 143 99 22 25
AZITHROMYCIN 138 120 23 39
OXYCODONE HCL 133 56 S2 24 75
HYDROCHLOROTHIAZIDE 129 117 25 15
PLAVIX 122 122 26 30
ATENOLOL 121 110 27 18
CRESTOR 119 113 28 19
TRIAMTERENE-HCTZ 118 112 29 58
WARFARIN SODIUM 118 108 29 11
PANTOPRAZOLE SODIUM 116 84 31 36
ALPRAZOLAM 115 95 32 128
AMITRIPTYLINE HCL 114 104 R 33 73
CITALOPRAM HBR 110 90 34 21
CIPROFLOXACIN HCL 108 92 35 65
ETODOLAC 100 79 36 225
VENLAFAXINE HCL ER 99 53 37 126
TAMSULOSIN HCL 98 81 38 32
FLUTICASONE PROPIONATE 97 72 39 44
FELODIPINE ER 96 89 40 112
RAMIPRIL 96 73 40 81
TRAMADOL HCL 95 77 42 22
ATORVASTATIN CALCIUM 95 87 42 13
RANITIDINE HCL 94 80 44 27
PREDNISONE 89 84 45 35
OXYCODONE HCL-ACETAMINOPHEN 87 33 S2 46 83
BUMETANIDE 84 65 47 154
OXYCODONE-ACETAMINOPHEN 83 51 S2 48 71
FLUOXETINE HCL 82 55 49 68
DICLOFENAC SODIUM 82 56 49 123
GLIMEPIRIDE 82 75 49 28
AMOX TR-POTASSIUM CLAVULANATE 81 60 52 129
METHYLPREDNISOLONE 79 66 53 124
CELEBREX 77 70 54 85
LOSARTAN-HYDROCHLOROTHIAZIDE 76 76 55 54
LEVOFLOXACIN 74 56 56 66
DIGOXIN 74 69 56 40
JANUVIA 73 57 58 53
SINGULAIR 70 56 59 60
SPIRONOLACTONE 68 42 60 62
WELCHOL 67 56 61 182
CARVEDILOL 65 65 62 23
LYRICA 65 37 62 67
AMOXICILLIN 61 45 64 100
SYNTHROID 60 59 65 46
ZALEPLON 60 38 65 322
PROPRANOLOL HCL 59 44 67 132
QUETIAPINE FUMARATE 58 35 68 80
DOXAZOSIN MESYLATE 57 57 69 131
BUPROPION HCL 56 26 70 332
FENOFIBRATE 55 40 71 64
VESICARE 55 51 71 234
DONEPEZIL HCL 54 54 73 29
ALLOPURINOL 54 48 73 38
ONDANSETRON HCL 53 40 75 269
PAROXETINE HCL 53 44 75 57
BISOPROLOL FUMARATE 52 41 77 201
GLYBURIDE 51 49 R 78 88
BENICAR HCT 50 50 79 179
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.